Ube2ftm1c(EUCOMM)Hmgu
Targeted Allele Detail
|
|
| Symbol: |
Ube2ftm1c(EUCOMM)Hmgu |
| Name: |
ubiquitin-conjugating enzyme E2F (putative); targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH |
| MGI ID: |
MGI:7738243 |
| Gene: |
Ube2f Location: Chr1:91177412-91214243 bp, + strand Genetic Position: Chr1, 46.08 cM
|
| Alliance: |
Ube2ftm1c(EUCOMM)Hmgu page
|
| IMPC: |
Ube2f gene page |
|
| Mutant Cell Line: |
HEPD0820_4_G09 |
| Germline Transmission: |
Earliest citation of germline transmission:
J:342795
|
| Parent Cell Line: |
JM8A3.N1 (ES Cell)
|
| Strain of Origin: |
C57BL/6N-Atm1Brd
|
| Project Collection: |
EUCOMM
|
|
| Allele Type: |
|
Targeted (Conditional ready) |
| Mutation: |
|
Insertion
Vector: L1L2_Bact_P
|
| |
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 91202481 of Chromosome 1 upstream of exon 5 (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site is inserted downstream of the targeted exon at position 91203328. The critical exon is thus flanked by loxP sites. A "conditional ready" (floxed) allele was created by flp recombinase expression in mice carrying this allele. Subsequent cre expression results in a knockout mouse. Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml
(J:157065, J:348744)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Ube2f Mutation: |
16 strains or lines available
|
|
| Original: |
J:342795 Wu D, et al., The Ube2m-Rbx1 neddylation-Cullin-RING-Ligase proteins are essential for the maintenance of Regulatory T cell fitness. Nat Commun. 2022 May 31;13(1):3021 |
| All: |
5 reference(s) |
|